MRTX
Assenagon Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,825,678
| Closed | -$79.5M | – | 1467 |
|
|
2023
Q3 | $79.5M | Buy |
1,825,678
+1,016,858
| +126% | +$44.3M | 0.25% | 57 |
|
|
2023
Q2 | $29.2M | Buy |
808,820
+552,860
| +216% | +$20M | 0.1% | 151 |
|
|
2023
Q1 | $9.52M | Buy |
255,960
+86,175
| +51% | +$3.2M | 0.03% | 380 |
|
|
2022
Q4 | $7.69M | Sell |
169,785
-23,643
| -12% | -$1.07M | 0.03% | 406 |
|
|
2022
Q3 | $13.5M | Sell |
193,428
-658,522
| -77% | -$46M | 0.05% | 270 |
|
|
2022
Q2 | $57.2M | Buy |
851,950
+798,528
| +1,495% | +$53.6M | 0.21% | 85 |
|
|
2022
Q1 | $4.39M | Sell |
53,422
-38,738
| -42% | -$3.18M | 0.01% | 528 |
|
|
2021
Q4 | $13.5M | Sell |
92,160
-270,440
| -75% | -$39.7M | 0.04% | 235 |
|
|
2021
Q3 | $64.1M | Sell |
362,600
-959
| -0.3% | -$170K | 0.21% | 72 |
|
|
2021
Q2 | $58.7M | Buy |
363,559
+72,021
| +25% | +$11.6M | 0.2% | 76 |
|
|
2021
Q1 | $49.9M | Buy |
291,538
+245,488
| +533% | +$42.1M | 0.2% | 71 |
|
|
2020
Q4 | $10.1M | Sell |
46,050
-82,750
| -64% | -$18.2M | 0.04% | 213 |
|
|
2020
Q3 | $21.4M | Buy |
128,800
+27,426
| +27% | +$4.55M | 0.12% | 97 |
|
|
2020
Q2 | $11.6M | Buy |
+101,374
| New | +$11.6M | 0.07% | 146 |
|